Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$29.66 - $44.0 $392,312 - $581,988
-13,227 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$43.09 - $82.26 $387,982 - $740,669
9,004 Added 213.21%
13,227 $569,000
Q2 2021

Aug 13, 2021

BUY
$52.03 - $68.77 $219,722 - $290,415
4,223 New
4,223 $275,000
Q3 2018

Nov 09, 2018

SELL
$189.1 - $282.92 $529,669 - $792,458
-2,801 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$114.22 - $133.22 $68,532 - $79,932
-600 Reduced 17.64%
2,801 $0
Q4 2017

Feb 12, 2018

SELL
$93.4 - $128.74 $569,926 - $785,571
-6,102 Reduced 64.21%
3,401 $0
Q3 2017

Nov 13, 2017

BUY
$91.08 - $104.49 $865,533 - $992,968
9,503
9,503 $904,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $210M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.